Skip to content

Feasibility of Comparing Two Surgical Treatment of Female Urodynamic Stress

Feasibility of Comparing Two Surgical Treatment of Female Urodynamic Stress Incontinence (SITOT)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01230450
Acronym
SITOT
Enrollment
137
Registered
2010-10-29
Start date
2009-11-30
Completion date
2011-10-31
Last updated
2013-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Stress Incontinence

Keywords

urodynamic urinary incontinence, sub-urethral tape

Brief summary

Aim: The study aim to assess the feasibly a large prospective multi-centre randomised study for comparing the relatively new Single incision sub-urethral tapes with the standard surgical treatment of female urodynamic stress incontinence (USI).

Detailed description

Single incision tension-free sub-urethral vaginal tapes procedures8 have been recently described in an attempt to avoid the blind passage of the trochars through the groin & the adductor muscles and consequently reducing the incidence & severity of postoperative leg pain. The obvious advantages would be shorter hospital stay, early recovery, early resumption of day to day activities & earlier return to work. A number of small prospective audits and case-series have been presented in international conferences reporting on the safety & outcomes for these procedures. However all these studies were for preliminary reports for proof of concept and therefore the studies populations were 15-70 women with short term follow-up of 2-3 month9-11.These studies have shown low perioperative complication rates: bladder injury 0-1%, vaginal erosion 1-3% & one study showing 1.3% pain at 6 weeks follow-up. The patient reported success rates were 77-93% at 2-3 month follow-up9-12. Objectives: 1. Establish the feasibility of the Single incision sub-urethral tapes to be done under local anaesthesia. 2. The feasibility of randomisation to the standard surgical treatment TVT-O / TVT. 3. To compare the surgical approach in this relatively new procedure against the standard procedures as regard: Peri-operative complication rates, Postoperative pain, Time to discharge from the hospital, 4. To compare the outcomes as regard: Patient-reported cure rates, Patient satisfaction, Impact on Quality of life (QoL) and sexual function at 3 month & 1 -year follow-up. The objective cure rates will be assessed at 3 month follow-up. Design: A pilot prospective randomised study within participating urogynaecology units of the Scottish Pelvic Floor Network.

Interventions

PROCEDUREsub-urethral tape (TVT-O)

Tension free vaginal tape vs. single incision sub-urethral tension free vaginal tape

OTHERstand standard mid-urethral sling (TVT-O)

Sponsors

Aberdeen Royal Infirmary
CollaboratorOTHER
University of Aberdeen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* USI * Mixed incontinence symptoms with predominantly bothering stress component (No DO on UDS). * Primary Incontinence Surgery. * BMI \< 35 * Ability to understand the information leaflet and sign an informed consent form in English. * All would have had failed or declined PFMT.

Exclusion criteria

* Mixed incontinence with pre-dominant OAB and/or Neurological conditions e.g. MS. * Detrusor Overactivity on Urodynamics. * Inability to understand English. * Un-willing for randomisation. * Concomitant surgery. * Patient requiring postoperative hospital-stay for medical or social reasons

Design outcomes

Primary

MeasureTime frameDescription
• Feasibility of the single incision sub-urethral tape to be done under local anaesthesia1 year* Feasibility of the single incision sub-urethral tape to be done under local anaesthesia? * Number of women approached and declining LA o Number of women in LA group converted to GA

Secondary

MeasureTime frameDescription
• Patient-reported Success rates1 yearPatient-reported Success rates o Assessed by PGI-I Very Much Improved/ Much Improved.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026